USPTO serial 79346461
ONCOCLEW
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 9, 2024
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONCOCLEW?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business administration; business administration and management; business management and administration; business management | ACTIVE | — |
| 042 | Conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical drug development services; inspection of pharmaceuticals for quality control purposes; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; scientific research in the field of pharmacology; medical laboratory services, namely, preparing and preserving tissue samples for use by others for medical research purposes; medicine research; product development consultation, namely, analysis and evaluation of medical product development; pharmaceutical product evaluation; medical and pharmacological research services; medical laboratory services, namely, performing biopsies for medical research; analysis of human tissues for medical research | ACTIVE | — |
| 044 | Medical services, namely, analysis of human biodata for medical purposes; providing information in the field of medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SG MEDICAL, INC.
- Other trademarks owned by ONCOCLEW CO., LTD.
- Other trademarks owned by ONCOCLEW CO., LTD.
- Other trademarks owned by ONCOCLEW CO., LTD.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOCLEW
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 11, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 10, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 10, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 9, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 24, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 4, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 30, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 30, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 30, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 24, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 23, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 23, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 23, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 2, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |